<DOC>
	<DOCNO>NCT01495338</DOCNO>
	<brief_summary>The purpose study evaluate safety comfort AC-170 compare placebo .</brief_summary>
	<brief_title>A Comparison Safety Comfort AC-170</brief_title>
	<detailed_description />
	<mesh_term>Cetirizine</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Able willing avoid use ocular medication topical ocular preparation within protocol specific time period . Known contraindication sensitivity study medication component . Any ocular condition , opinion investigator , could affect subject safety trial parameter . Use disallow medication period indicate prior study enrollment study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>